Blog
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Blog
Jul 2, 2024, 09:57 |
Blog
Yüksel Ürün: Misinformation about cancer on social media is a critical issue
Yüksel Ürün shared on X: . "Misinformation about cancer…
Jul 2, 2024, 09:37 |
Blog
Douglas Flora: Our June issue of AI in Precision Oncology
Douglas Flora shared a post by AI in Precision Oncology, on LinkedIn: "It’s here! Our June…
Jul 2, 2024, 09:30 |
Blog
Aman Khera: The FDA DAP updated draft guidance is out
Aman Khera, Vice President of Regulatory Science and Innovation at Worldwide Clinical Trials, shared on LinkedIn:…
Jul 2, 2024, 09:21 |
Blog
Rana McKay: Our GU Oncology Highlights from ASCO with Neeraj Agarwal
Rana McKay shared a post on X: . "Check…
Jul 2, 2024, 09:16 |
Blog
Phuong Ly-Gallagher: Have you ever heard of an 'oncogeneralist?'
Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared a…
Jul 2, 2024, 09:15 |
Blog
Implementation of ChildGICR education programme on Cancer Registry Development - IARC
IARC shared a post on LinkedIn: “Researchers from International Agency for Research on Cancer (IARC) and…
Jul 2, 2024, 08:55 |
Blog
Mark Wildgust: Another incredible milestone for our JNJOncology team!
Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson and…
Jul 2, 2024, 08:34 |
Blog
Aruni Ghose: Looking forward to collaborate more on Geriatric Oncology presentations around UK
Aruni Ghose shared a post by Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared…
Jul 2, 2024, 08:27 |
Blog
Symbol of hope and excellence in cancer care - Ethiopian Society of Hematology and Oncology (ESHO)
Ethiopian Society of Hematology and Oncology-ESHO made the following post on LinkedIn: “Today, the Ethiopian…
Jul 2, 2024, 08:18 |
Blog
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…
227
228
229
230
231
All:
10774
Posts:
2281 - 2290
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
Facebook
RSS Feed
Twitter
Linkedin
Youtube